In addition, we not only elucidated the expression and prognostic value of RFX1 in colon cancer using multi-omics analysis, but also innovatively introduced persistent tumor mutational burden (pTMB) as a co-stratification tool. The gene discussed is RFX1; the disease is neoplasm.